Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Amortization of Deferred Charges: 2017-2018

Historic Amortization of Deferred Charges for Cogent Biosciences (COGT) over the last 2 years, with Dec 2018 value amounting to $7,000.

  • Cogent Biosciences' Amortization of Deferred Charges rose 16.67% to $7,000 in Q4 2018 from the same period last year, while for Dec 2018 it was $23,000, marking a year-over-year increase of 15.00%. This contributed to the annual value of $23,000 for FY2018, which is 15.00% up from last year.
  • According to the latest figures from Q4 2018, Cogent Biosciences' Amortization of Deferred Charges is $7,000, which was up 40.00% from $5,000 recorded in Q3 2018.
  • Cogent Biosciences' 5-year Amortization of Deferred Charges high stood at $7,000 for Q4 2018, and its period low was $4,000 during Q1 2017.
  • Moreover, its 2-year median value for Amortization of Deferred Charges was $5,000 (2018), whereas its average is $5,375.
  • Data for Cogent Biosciences' Amortization of Deferred Charges shows a peak YoY increased of 25.00% (in 2018) over the last 5 years.
  • Quarterly analysis of 2 years shows Cogent Biosciences' Amortization of Deferred Charges stood at $6,000 in 2017, then grew by 16.67% to $7,000 in 2018.
  • Its last three reported values are $7,000 in Q4 2018, $5,000 for Q3 2018, and $6,000 during Q2 2018.